- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04892173
NBTXR3 Met of zonder Cetuximab in LA-HNSCC
Een fase 3-studie van NBTXR3 geactiveerd door de keuze van de onderzoeker voor radiotherapie alleen of radiotherapie in combinatie met cetuximab voor op platina gebaseerde chemotherapie die niet in aanmerking komt voor oudere patiënten met LA-HNSCC
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studiecontact
- Naam: Study Contact
- Telefoonnummer: 844-434-4210
- E-mail: Participate-In-This-Study1@its.jnj.com
Studie Locaties
-
-
-
Brussels, België, 1200
- Werving
- Cliniques Universitaires Saint Luc
-
Charleroi, België, 6060
- Voltooid
- Grand Hopital De Charleroi Site Les Viviers
-
Leuven, België, 3000
- Werving
- Universitair Ziekenhuis Leuven
-
-
-
-
-
Barretos, Brazilië, 14784-400
- Werving
- Fundacao Pio XII
-
Belo Horizonte, Brazilië, 30380 472
- Werving
- Nucleo de Ensino e Pesquisa do Instituto Mario Penna
-
Fortaleza, Brazilië, 60336 232
- Voltooid
- Centro Regional Integrado de Oncologia CRIO
-
Fortaleza, Brazilië, 60430-230
- Werving
- Instituto Do Cancer Do Ceara
-
Ipatinga, Brazilië, 35160 158
- Werving
- Fundacao Sao Francisco Xavier
-
Jaú, Brazilië, 17210 080
- Werving
- Fundacao Doutor Amaral Carvalho
-
Londrina, Brazilië, 86015 520
- Werving
- Hospital do Cancer de Londrina
-
Porto Alegre, Brazilië, 90610-000
- Werving
- Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS
-
Porto Alegre, Brazilië, 91350-200
- Voltooid
- Hospital Nossa Senhora da Conceicao
-
Porto Alegre, Brazilië, 90050 170
- Werving
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Rio de Janeiro, Brazilië, 22 250 905
- Werving
- Oncoclinicas Rio de Janeiro S A
-
Salvador, Brazilië, 41950 640
- Werving
- Ensino e Terapia de Inovacao Clinica AMO Etica
-
São José do Rio Preto, Brazilië, 15090-000
- Werving
- Funfarme Sjrp
-
São Paulo, Brazilië, 01246 000
- Werving
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, Brazilië, 01308 050
- Werving
- Sociedade Beneficente de Senhoras Hospital Sirio Libanes
-
Vitória, Brazilië, 29043 260
- Werving
- Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia
-
-
-
-
-
Panagyurishte, Bulgarije, 4500
- Voltooid
- MHAT Uni Hospital
-
Sofia, Bulgarije, 1756
- Voltooid
- Specialized Hospital for Active Treatment in Oncology
-
-
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Werving
- Sunnybrook Health Sciences Center
-
-
-
-
-
Bengbu, China, 233004
- Voltooid
- The Affiliated Hospital of Bengbu Medical College
-
Changsha, China, 410008
- Voltooid
- Xiangya Hospital Central South University
-
Changsha, China, 410013
- Werving
- Hunan Cancer hospital
-
Chengdu, China, 610041
- Werving
- Sichuan Cancer Hospital
-
Dongguan, China, 523109
- Werving
- Dongguan People s Hospital
-
Fuzhou, China, 350005
- Werving
- The First Affiliated Hospital of Fujian Medical University
-
Fuzhou, China, 350001
- Voltooid
- Fujian Medical University Union Hospital
-
Fuzhou, China, 350014
- Werving
- Fujian Medical University Fujian Provincial Cancer Hospital
-
Guangzhou, China, 510180
- Werving
- Guangzhou First Municipal People's Hospital
-
Guangzhou, China, 510080
- Werving
- The First Affiliated Hospital of Guangdong Pharmaceutical University
-
Guangzhou, China, 510095
- Werving
- Guangzhou Medical University Affiliated Oncology Hospital
-
Jinan, China, 250012
- Werving
- Qilu Hospital of Shandong University
-
Jinan, China, 250117
- Werving
- Shandong Cancer Hospital
-
Linyi, China, 276002
- Werving
- Linyi Cancer Hospital
-
Liuzhou, China, 545006
- Werving
- Liuzhou people's Hospital
-
Nanchang, China, 330029
- Voltooid
- Jiangxi Cancer Hospital
-
Nanjing, China, 223800
- Werving
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
-
Nanjing, China, 210009
- Voltooid
- Jiangsu Cancer Hospital
-
Nanning, China, 530000
- Werving
- Wuming Hospital of Guangxi Medical University
-
Nanning, China, 530021
- Werving
- The Cancer Hospital Affiliated to Guangxi Medical University
-
Qingdao, China, 266003
- Werving
- The Affiliated Hospital of Medical College Qingdao University
-
Shanghai, China, 200032
- Voltooid
- Fudan University Shanghai Cancer Center
-
Shenyang, China, 110042
- Voltooid
- Liaoning Cancer Hospital and Institute
-
Shenzhen, China, 518036
- Werving
- Peking University Shenzhen Hospital
-
Shijiazhuang, China, 50011
- Werving
- The Fourth Hospital of Hebei Medical University
-
Suzhou, China, 215004
- Voltooid
- Second Affiliated Hospital, SooChow University
-
Taiyuan, China, 30013
- Voltooid
- Shanxi Provincial Cancer hospital
-
Tianjin, China, 300060
- Voltooid
- Tianjin Medical University Cancer Institute and Hospital
-
Wuhan, China, 430022
- Werving
- Union Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Wuhan, China, 430079
- Werving
- Hubei Cancer Hospital
-
Wuhan, China, 430030
- Werving
- Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Xiamen, China, 361003
- Voltooid
- The first affiliated hospital of xiamen university
-
Xuzhou, China, 221000
- Voltooid
- The Affiliated Hospital of Xuzhou Medical University
-
Zhengzhou, China, 450008
- Voltooid
- Henan Cancer Hospital
-
Zhuhai, China, 519000
- Werving
- The Fifth Affiliated Hospital Sun Yat Sen University
-
-
-
-
-
Giessen, Duitsland, 35392
- Werving
- Universitaetsklinikum Giessen und Marburg GmbH
-
Hanover, Duitsland, 30625
- Werving
- Medizinische Hochschule Hannover
-
Jena, Duitsland, 07747
- Voltooid
- Universitatsklinikum Jena
-
München, Duitsland, 81675
- Voltooid
- Klinikum rechts der Isar an der Technischen Universitat Munchen
-
Rostock, Duitsland, 18059
- Voltooid
- Universitaetsmedizin Rostock
-
-
-
-
-
Las Piñas, Filippijnen, 1742
- Voltooid
- University of Perpetual Help Dalta Medical Center, Inc
-
Manila, Filippijnen, 1000
- Voltooid
- Manila Doctors Hospital
-
Pasig, Filippijnen, 1600
- Actief, niet wervend
- The Medical City
-
Quezon City, Filippijnen, 1112
- Voltooid
- St. Luke's Medical Center
-
-
-
-
-
Tampere, Finland, 33520
- Voltooid
- Tampereen Yliopistollinen Sairaala
-
-
-
-
-
Amiens, Frankrijk, 80000
- Werving
- CHU Amiens Picardie
-
Brest, Frankrijk, 29609
- Werving
- CHU Brest
-
Caen, Frankrijk, 14076
- Werving
- Centre Francois Baclesse
-
Dijon, Frankrijk, 21000
- Werving
- Centre Georges Francois Leclerc
-
Lille, Frankrijk, 59020
- Werving
- Centre de Lutte contre le Cancer Centre Oscar Lambret
-
Lyon, Frankrijk, 69008
- Voltooid
- Centre Leon Berard
-
Marseille, Frankrijk, 13385
- Werving
- Hopital de la Timone
-
Neuilly-sur-Seine, Frankrijk, 92200
- Voltooid
- Clinique Ambroise Pare
-
Paris, Frankrijk, 75248
- Werving
- Institut Curie
-
Paris, Frankrijk, 75015
- Werving
- Hopital Europeen Georges Pompidou
-
Paris, Frankrijk, 75970
- Werving
- Hopital Tenon
-
Pessac, Frankrijk, 33604
- Werving
- Hopital Haut Leveque
-
Rennes, Frankrijk, 35000
- Werving
- Hopital Pontchaillou
-
Rouen, Frankrijk, 76038
- Werving
- CLCC - Centre Henri Becquerel
-
Saint-Etienne, Frankrijk, 42055
- Werving
- CHU Saint Etienne
-
Valenciennes, Frankrijk, 59322
- Voltooid
- Centre Hospitalier de Valenciennes Hopital Jean Bernard
-
Vandœuvre-lès-Nancy, Frankrijk, 54500
- Werving
- Institut de Cancerologie de Lorraine
-
Villejuif, Frankrijk, 94805
- Werving
- Gustave Roussy
-
-
-
-
-
Batumi, Georgië, 6000
- Werving
- High Technology Hospital MedCenter Ltd Batumi
-
Kutaisi, Georgië, 4600
- Werving
- JSC Vian Kutaisi Referral Hospital
-
Tbilisi, Georgië, 0112
- Voltooid
- Todua Clinic
-
Tbilisi, Georgië, 144
- Werving
- Ltd Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
-
-
-
-
-
Athens, Griekenland, 124 62
- Werving
- University General Hospital Attikon General Hospital Of West Attica H Agia Varvara
-
Larissa, Griekenland, 41110
- Werving
- University Hospital Of Larissa
-
Thessaloniki, Griekenland, 57001
- Voltooid
- Interbalkan Medical Center of Thessaloniki
-
Thessaloniki, Griekenland, 54639
- Werving
- Athens Medical Center S A Interbalkan Medical Center of Thessaloniki
-
-
-
-
-
Budapest, Hongarije, 1062
- Voltooid
- Eszak Pesti Centrumkorhaz Honvedkorhaz
-
Budapest, Hongarije, 1122
- Werving
- Orszagos Onkologiai Intezet
-
Szeged, Hongarije, 6720
- Werving
- Szent Gyorgyi Albert Klinikai Kozpont Onkoterapias Klinika
-
-
-
-
-
Bangalore, Indië, 560054
- Werving
- M S Ramaiah Memorial Hospital
-
Chennai, Indië, 600035
- Voltooid
- Apollo Speciality Hospital, Chennai
-
Madurai, Indië, 625107
- Voltooid
- Meenakshi Mission Hospital and Research Center
-
Mumbai, Indië, 400012
- Werving
- Tata Memorial Hospital
-
Nashik, Indië, 422002
- Werving
- HealthCare Global HCG Manavata Cancer Centre
-
New Delhi, Indië, 110085
- Werving
- Rajiv Gandhi Cancer Institute and Research Centre
-
Pune, Indië, 411 001
- Voltooid
- Grant Medical foundation Ruby Hall Clinic
-
Vijayawada, Indië, 520002
- Werving
- HCG cancer center
-
-
-
-
-
Ashdod, Israël, 7747629
- Actief, niet wervend
- Samson Assuta Ashdod University Hospital
-
Haifa, Israël, 3109601
- Voltooid
- Rambam Health Care Campus
-
Jerusalem, Israël, 9112001
- Voltooid
- Hadassah Medical Center
-
Tel Aviv, Israël, 6423906
- Voltooid
- Tel Aviv Sourasky Medical Center
-
-
-
-
-
Bunkyō City, Japan, 113-8519
- Werving
- Tokyo Medical and Dental University Hospital
-
Hiroshima, Japan, 734 8551
- Werving
- Hiroshima University Hospital
-
Kashiwa, Japan, 277-8577
- Werving
- National Cancer Center Hospital East
-
Nagoya, Japan, 464-8681
- Werving
- Aichi Cancer Center
-
Osaka, Japan, 541 8567
- Werving
- Osaka International Cancer Institute
-
Osaka Sayama Shi, Japan, 589 8511
- Voltooid
- Kindai University Hospital
-
Sendai, Japan, 980 8574
- Werving
- Tohoku University Hospital
-
Shimotsuke, Japan, 329-0498
- Werving
- Jichi Medical University Hospital
-
Shinjuku, Japan, 160 0023
- Werving
- Tokyo Medical University Hospital
-
Sunto Gun, Japan, 411 8777
- Werving
- Shizuoka Cancer Center
-
-
-
-
-
Zagreb, Kroatië, 10000
- Voltooid
- Klinicki bolnicki centar Zagreb
-
-
-
-
-
Graz, Oostenrijk, 8036
- Voltooid
- Medizinische Universitat Graz
-
Innsbruck, Oostenrijk, 6020
- Werving
- Medical University Innsbruck
-
Linz, Oostenrijk, 4010
- Werving
- Ordensklinikum Linz GmbH Barmherzige Schwestern
-
Vienna, Oostenrijk, 1090
- Werving
- Medizinische Universitaet Wien
-
-
-
-
-
Braga, Portugal, 4710 243
- Voltooid
- Uls Braga - Hosp. Braga
-
Lisbon, Portugal, 1649 035
- Voltooid
- Uls Santa Maria - Hosp. Santa Maria
-
Lisbon, Portugal, 1998050
- Werving
- Hosp. Cuf Descobertas
-
Porto, Portugal, 4099-001
- Voltooid
- Uls Santo Antonio - Hosp. Santo Antonio
-
Vila Nova de Gaia, Portugal, 4434 502
- Werving
- Uls Gaia Espinho
-
-
-
-
-
Bucharest, Roemenië, 22328
- Actief, niet wervend
- Institutul Oncologic Prof Dr Al Trestioreanu Bucuresti
-
-
-
-
-
Belgrade, Servië, 11000
- Voltooid
- Institute of Oncology and Radiology of Serbia
-
Belgrade, Servië, 11000
- Voltooid
- Vojnomedicinska Akademija
-
Kamenitz, Servië, 21204
- Voltooid
- Institute of Oncology of Vojvodina
-
Kragujevac, Servië, 34000
- Voltooid
- University Clinical Center Kragujevac
-
-
-
-
-
Barakaldo, Spanje, 48903
- Werving
- Hosp. Univ. de Cruces
-
Barcelona, Spanje, 8035
- Werving
- Hosp Univ Vall D Hebron
-
Barcelona, Spanje, 08036
- Voltooid
- Hosp Clinic de Barcelona
-
Jerez de la Frontera, Spanje, 11407
- Werving
- Hosp. de Jerez de La Frontera
-
L'Hospitalet de Llobregat, Spanje, 08908
- Werving
- Instituto Catalan Deoncologia Hospital Duran I Reynals
-
Las Palmas de Gran Canaria, Spanje, 35001
- Voltooid
- Hospitales Universitarios San Roque En Las Palmas de Gran Canaria Centro Oncologico Integral Canario
-
Lugo, Spanje, 27003
- Werving
- Hosp. Univ. Lucus Augusti
-
Madrid, Spanje, 28041
- Werving
- Hosp. Univ. 12 de Octubre
-
Madrid, Spanje, 28007
- Werving
- Hosp. Gral. Univ. Gregorio Maranon
-
Madrid, Spanje, 28040
- Werving
- Hosp Univ Fund Jimenez Diaz
-
Madrid, Spanje, 28050
- Voltooid
- Hosp Univ Hm Sanchinarro
-
Málaga, Spanje, 29010
- Werving
- Hosp Regional Univ de Malaga
-
Pamplona, Spanje, 31008
- Voltooid
- Hosp. de Navarra
-
Sabadell, Spanje, 08208
- Werving
- Hosp.Univ.Parc Tauli
-
Santander, Spanje, 39008
- Werving
- Hosp. Univ. Marques de Valdecilla
-
Seville, Spanje, 41013
- Werving
- Hosp. Virgen Del Rocio
-
Valencia, Spanje, 46014
- Werving
- Hosp. Gral. Univ. Valencia
-
Valencia, Spanje, 46009
- Werving
- Inst. Valenciano de Oncologia
-
Zaragoza, Spanje, 50009
- Werving
- Hosp. Clinico Univ. Lozano Blesa
-
-
-
-
-
Bei Qu, Taiwan, 704
- Werving
- National Cheng Kung University Hospital
-
Changhua, Taiwan, 500
- Werving
- Changhua Christian Hospital
-
Keelung, Taiwan, 20442
- Werving
- Chang-Gung Memorial Hospital-Keelung
-
Taichung, Taiwan, 40705
- Werving
- Taichung Veterans General Hospital
-
Taipei, Taiwan, 100
- Werving
- National Taiwan University Hospital
-
-
-
-
-
Olomouc, Tsjechië, 779 00
- Voltooid
- Fakultni nemocnice Olomouc
-
Prague, Tsjechië, 180 81
- Actief, niet wervend
- Nemocnice Bulovka
-
-
-
-
-
Edinburgh, Verenigd Koninkrijk, EH4 2XU
- Werving
- Western General Hospital
-
Glasgow, Verenigd Koninkrijk, G12 0YN
- Werving
- NHS Greater Glasgow and Clyde
-
Guildford, Verenigd Koninkrijk, GU2 7XX
- Werving
- The Royal Surrey County Hospital NHS Foundation Trust
-
London, Verenigd Koninkrijk, SW3 6JJ
- Werving
- The Royal Marsden NHS Trust
-
Newcastle upon Tyne, Verenigd Koninkrijk, NE7 7DN
- Werving
- Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Nottingham, Verenigd Koninkrijk, NG5 1PB
- Werving
- Nottingham City Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35294
- Werving
- University of Alabama at Birmingham
-
-
California
-
Duarte, California, Verenigde Staten, 91010
- Werving
- City of Hope
-
La Jolla, California, Verenigde Staten, 92093
- Werving
- University of California at San Diego Moores Cancer Center
-
Laguna Hills, California, Verenigde Staten, 92653
- Voltooid
- Memorial Radiation Oncology Medical Group Laguna Hills
-
Los Angeles, California, Verenigde Staten, 90095
- Werving
- UCLA Hematology Oncology
-
Newport Beach, California, Verenigde Staten, 92663
- Voltooid
- Hoag Memorial Hospital
-
San Francisco, California, Verenigde Staten, 94158
- Werving
- University of California San Francisco
-
-
District of Columbia
-
Washington D.C., District of Columbia, Verenigde Staten, 20052
- Werving
- George Washington University Cancer Center
-
-
Florida
-
Jacksonville, Florida, Verenigde Staten, 32224
- Werving
- Mayo Clinic Jacksonville
-
Orlando, Florida, Verenigde Staten, 32803
- Werving
- AdventHealth Orlando
-
Tampa, Florida, Verenigde Staten, 33612
- Werving
- Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30308
- Werving
- Emory University Hospital Midtown
-
-
Kentucky
-
Lexington, Kentucky, Verenigde Staten, 40536
- Werving
- University of Kentucky Markey Cancer Center
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02118
- Werving
- Boston Medical Center
-
-
New Mexico
-
Santa Fe, New Mexico, Verenigde Staten, 87505
- Voltooid
- Christus St. Vincent Regional Cancer Center
-
-
New York
-
New York, New York, Verenigde Staten, 10032
- Voltooid
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center
-
Staten Island, New York, Verenigde Staten, 10310
- Werving
- Richmond University Medical Center
-
The Bronx, New York, Verenigde Staten, 10467
- Werving
- Montefiore Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, Verenigde Staten, 27514
- Werving
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, Verenigde Staten, 28204
- Werving
- Atrium Health Levine Cancer Institute
-
-
Ohio
-
Cincinnati, Ohio, Verenigde Staten, 45219
- Werving
- University of Cincinnati
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Verenigde Staten, 73104
- Werving
- Stephenson Cancer Center
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97239
- Werving
- Oregon Health And Science University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104
- Werving
- University of Pennsylvania Perelman Center for Advanced Medicine
-
-
Virginia
-
Charlottesville, Virginia, Verenigde Staten, 22908
- Werving
- University of Virginia
-
Norfolk, Virginia, Verenigde Staten, 23507
- Werving
- Macon Joan Brock Virginia Health Sciences Eastern Virginia Medical Group at Old Dominion University
-
-
-
-
-
Seoul, Zuid -Korea, 05505
- Werving
- Asan Medical Center
-
Seoul, Zuid -Korea, 03722
- Werving
- Severance Hospital Yonsei University Health System
-
Seoul, Zuid -Korea, 06591
- Voltooid
- The Catholic University of Korea Seoul St Mary s Hospital
-
Suwon, Zuid -Korea, 16247
- Werving
- The Catholic university of Korea, St. Vincent's Hospital
-
-
-
-
-
Gothenburg, Zweden, 41345
- Voltooid
- Sahlgrenska Universitetssjukhuset
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
Age greater than or equal to (>=) 60 years old
-
Biopsy-confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or supraglottic larynx and a candidate for definitive radiation therapy with or without cetuximab
-
Clinical stage T3-4 NX or T2 N2-3 disease according to the 8th edition of AJCC
-
One primary tumor lesion amendable for intratumoral injection
-
Ineligible to receive platinum-based chemotherapy with radiation (at least one of the following):
- Estimated creatinine clearance >= 30 and less than (<) 50 milliliters/minute (mL/min) (per Cockcroft-Gault equation),
- Grade >= 2 hearing loss or tinnitus,
- Grade >= 2 peripheral neuropathy,
- New York Heart Association Class 3
- Aged 70-74 years old with Geriatric 8 (G8) score less than or equal to (<=) 14 or Aged >= 75 years old
-
Eastern cooperative oncology group (ECOG) performance status 0 to 1
-
Life expectancy >= 6 months
Exclusion Criteria:
- Carcinoma of the nasopharynx, paranasal sinus, salivary gland, or thyroid gland; or non-squamous histology or SCC of unknown primary origin
- Clinical stage T1-2 N0, T2 N1, or M1 disease according to the 8th edition of AJCC
- Loco-regionally recurrent head & neck cancer that has been previously treated with surgery, radiation therapy, and/or chemotherapy
- Prior or concurrent primary malignancy (including second synchronous head & neck cancer) within the last 2 years of informed consent and whose natural history has the potential to interfere with the safety and efficacy assessment of the investigational agent
- Ongoing or active infection requiring treatment with antimicrobial therapy within 2 weeks of randomization
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Arm A: JNJ-90301900 (NBTXR3)
JNJ-90301900 (NBTXR3), as an intratumoral/intranodal injection, activated by investigator's choice of RT alone or RT in combination with cetuximab. JNJ-90301900 (NBTXR3) is given as a dose of 33% of the Gross Tumor Volume. |
Suspension of inert, crystalline hafnium oxide particles, designed to generate oxygen free radicals to destroy cancer cells after activation by ionizing radiation.
Andere namen:
Solution for infusion
Andere namen:
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period. |
|
Actieve vergelijker: Arm B: RT alone or RT in combination with cetuximab
Investigator's choice of RT alone or RT in combination with cetuximab. |
Solution for infusion
Andere namen:
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Progression-free Survival (PFS) Based on Independent Central Review (ICR)
Tijdsspanne: 30 months following first randomized participant
|
PFS is defined as time from randomization to local-regional progression (including recurrence), distant progression, or death from any cause, whichever occurs first. |
30 months following first randomized participant
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Overall Survival (OS)
Tijdsspanne: 48 months following first randomized participant
|
Time from randomization to death from any cause. |
48 months following first randomized participant
|
|
Local-regional control
Tijdsspanne: 48 months following first randomized participant
|
Time to local regional progression: time from randomization to local-regional progression (including recurrence) or death, whichever occurs first. |
48 months following first randomized participant
|
|
Distant control
Tijdsspanne: 48 months following first randomized participant
|
Time to distant progression: time from randomization to distant progression or death, whichever occurs first. |
48 months following first randomized participant
|
|
Quality of Life over time - QLQ H&N35
Tijdsspanne: 48 months following first randomized participant
|
Change from baseline over time in symptoms, function, and health related QOL using the European organisation for research and treatment of cancer (EORTC) questionnaire-head and neck cancer module (QLQ H&N35). |
48 months following first randomized participant
|
|
Quality of Life over time - EQ 5D 5L
Tijdsspanne: 48 months following first randomized participant
|
Change from baseline over time in symptoms, function, and health related QOL using the 5 level EuroQol 5 dimension (EQ 5D 5L) instrument. |
48 months following first randomized participant
|
|
Safety across duration of study - AEs
Tijdsspanne: 48 months following first randomized participant
|
Adverse events (AEs). |
48 months following first randomized participant
|
|
Objective Response Rate (ORR)
Tijdsspanne: 48 months following first randomized participant
|
Rate of complete response (CR)+partial response (PR) [RESIST 1.1]. |
48 months following first randomized participant
|
|
Duration of Overall Response
Tijdsspanne: 48 months following first randomized participant
|
Time from CR or PR to progression of disease, unequivocal clinical progression, or death, whichever occurs first. |
48 months following first randomized participant
|
|
Head and Neck Cancer Specific Event-Free Survival
Tijdsspanne: 48 months following first randomized participant
|
Time from randomization to loco regional progression (including recurrence), distant progression, or head and neck cancer related death, as per RECIST 1.1, whichever occurs first. |
48 months following first randomized participant
|
|
Head and Neck Cancer-Specific Survival
Tijdsspanne: 48 months following first randomized participant
|
Time from randomization to head and neck cancer-related death. |
48 months following first randomized participant
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Johnson & Johnson Enterprise Innovation Inc Clinical trial, Johnson & Johnson Enterprise Innovation Inc.
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Neoplasmata per site
- Neoplasmata
- Neoplasmata per histologisch type
- Hoofd- en nekneoplasmata
- Neoplasmata, glandulair en epitheel
- Carcinoom
- Neoplasmata, plaveiselcel
- Plaveiselcelcarcinoom van hoofd en hals
- Carcinoom, plaveiselcel
- Aminozuren, peptiden en eiwitten
- Eiwitten
- Therapeutica
- Antilichamen, monoklonaal, gehumaniseerd
- Antilichamen, monoklonaal
- Antilichamen
- Immunoglobulinen
- Immunoproteïnen
- Bloedeiwitten
- Serum -globulines
- Globulines
- Cetuximab
- Radiotherapie
Andere studie-ID-nummers
- NANORAY-312
- NANORAY-312 (Andere identificatie: Janssen Research & Development, LLC)
- 2024-520386-31-00 (Register-ID: EUCT number)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .